TNYA
Tenaya Therapeutics·NASDAQ
--
--(--)
--
--(--)
5.77 / 10
Netural
Capital flows are robust (fund-flow score 7.81/10), with positive trends in block and extra-large transactions, despite negative small- and medium-sized flows. Analyst sentiment is overwhelmingly bullish (100% Strong Buy among three analysts), but the historical win rates vary (40-50%). The Nasdaq bid-price warning adds regulatory uncertainty, tempering the otherwise supportive money-flow and analyst signals.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-12-12
InstitutionChardan Capital
Times predicted5
Historical Win Rate40.0%
What is the market sentiment for TNYA?
- TNYA holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 5.77/10 (Netural).
